title: Colonization by Candida in children with cancer, children with cystic fibrosis, and healthy controls.
abstract: A longitudinal, prospective study was conducted intermittently in Norway, from 1999 to 2008, to investigate the Candida colonization rates and species distributions in the tonsillopharyngeal and faecal flora in: (i) children with cancer; (ii) children with cystic fibrosis (CF); and (iii) healthy children. The effect of antibiotic treatment on Candida colonization was also studied, and we looked for changes in antifungal susceptibility over time within each child and between the different groups of children. In total, 566 tonsillopharyngeal swabs and 545 faecal samples were collected from 45 children with cancer, 37 children with CF, and 71 healthy, age-matched controls. The overall colonization rate with Candida was not significantly higher in the two groups of children undergoing extensive treatment with broad-spectrum antibiotics than in healthy controls. Approximately one-third of the cancer patients had a total lack of Candida colonization or had only one Candida-positive sample, despite multiple samples being taken, treatment with broad-spectrum antibiotics, long hospital stays, and periods with neutropenia. Children with CF had the highest prevalence of Candida albicans. Amoxycillin, azithromycin, third-generation cephalosporins and oral vancomycin resulted in a significantly increased Candida colonization rate. Phenoxymethylpenicillin, second-generation cephalosporins, metronidazole, trimethoprim-sulphamethoxazole, ciprofloxacin, penicillinase-resistant penicillins and inhaled tobramycin or colistin showed minimal effects on the Candida colonization rate. We found no evidence of development of antifungal resistance over time.
authors: Department of Paediatrics, Oslo University Hospital, Oslo, Norway. k.w.gammelsrud@medisin.uio.no
authors: K W
authors: KW
authors: Gammelsrud
authors: P
authors: P
authors: Sandven
authors: E A
authors: EA
authors: Høiby
authors: L
authors: L
authors: Sandvik
authors: P
authors: P
authors: Brandtzaeg
authors: P
authors: P
authors: Gaustad
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000494:pharmacology; D002175:Candida / Q000145:classification* / Q000187:drug effects / Q000302:isolation & purification; D002177:Candidiasis / Q000453:epidemiology*; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications*; D005243:Feces / Q000382:microbiology; D006801:Humans; D007223:Infant; D008137:Longitudinal Studies; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications*; D009664:Norway / Q000453:epidemiology; D014066:Palatine Tonsil / Q000382:microbiology; D010614:Pharynx / Q000382:microbiology; D015995:Prevalence; D011446:Prospective Studies
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents